Dr. Ivan Foledvari auf dem Paediatric Rheumatology Kongress, 29. September 2023

Vortrag:
A turning point in JIA treatment for the appropriate patient: Exploring tofacitinib’s role: „The current JIA treatment paradigm and unmet needs“

https://www.pres.eu/pres2023/satellite-symposia-meet-the-expert-sessions.html